Literature DB >> 2916405

The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times.

A V Bruschke1, J R Kramer, E T Bal, I U Haque, R C Detrano, M Goormastic.   

Abstract

To study the dynamics of progression of coronary atherosclerosis we analyzed findings in 168 patients who underwent coronary arteriography three times without undergoing coronary surgery or percutaneous transluminal coronary angioplasty. Of 66 patients who had progression in interval 1 (from first to second coronary arteriogram), 32 also had progression in interval 2 (from second to third coronary arteriogram); of 102 patients who had no progression in interval 1, 37 had progression in interval 2. In only 9 of the 32 patients who had progression during both intervals was the same lesion involved, and in six of these patients other lesions were also involved. Progression correlated with the duration of the interval between catheterizations, an increase in symptoms, and the occurrence of myocardial infarction. Analysis of variance showed no significant differences in mean values for age, blood pressure, total serum cholesterol, and serum triglycerides in the four main progression groups. Progression of coronary atherosclerosis is a highly unpredictable process. It follows a nonlinear course, and information derived from sequential coronary arteriograms is of little value in predicting future progression.

Entities:  

Mesh:

Year:  1989        PMID: 2916405     DOI: 10.1016/0002-8703(89)90772-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  15 in total

Review 1.  Arterial thrombosis--insidious, unpredictable and deadly.

Authors:  Shaun P Jackson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Mechanisms of progression in native coronary artery disease: role of healed plaque disruption.

Authors:  J Mann; M J Davies
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

Review 3.  Nonacute coronary syndrome anginal chest pain.

Authors:  Megha Agarwal; Puja K Mehta; C Noel Bairey Merz
Journal:  Med Clin North Am       Date:  2010-03       Impact factor: 5.456

4.  High-grade culprit lesions are a common cause of ST-segment elevation myocardial infarction.

Authors:  Michael Liang; Takashi Kajiya; Mark Y Chan; Edgar Tay; Chi-Hang Lee; Arthur Mark Richards; Adrian F Low; Huay Cheem Tan
Journal:  Singapore Med J       Date:  2015-06       Impact factor: 1.858

Review 5.  The independent roles of diet and serum lipids in the 20th-century rise and decline of coronary heart disease mortality.

Authors:  R H Rosenman
Journal:  Integr Physiol Behav Sci       Date:  1993 Jan-Mar

Review 6.  Monocyte heterogeneity in cardiovascular disease.

Authors:  Peter Libby; Matthias Nahrendorf; Filip K Swirski
Journal:  Semin Immunopathol       Date:  2013-07-10       Impact factor: 9.623

7.  Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery.

Authors:  Jorge Chiquie Borges; Neuza Lopes; Paulo R Soares; Aécio F T Góis; Noedir A Stolf; Sergio A Oliveira; Whady A Hueb; Jose A F Ramires
Journal:  J Cardiothorac Surg       Date:  2010-10-26       Impact factor: 1.637

8.  Novel approach to the interpretation of long-term "deterioration" in ejection fraction in individual patients with coronary artery disease.

Authors:  R Lim; L Dyke; J Thomas; D S Dymond
Journal:  Br Heart J       Date:  1993-09

Review 9.  Devices in heart failure: potential methods for device-based monitoring of congestive heart failure.

Authors:  Shahzeb M Munir; Roberta C Bogaev; Ed Sobash; K J Shankar; Sreedevi Gondi; Igor V Stupin; Jillian Robertson; M Alan Brewer; S Ward Casscells; Reynolds M Delgado; Amany Ahmed
Journal:  Tex Heart Inst J       Date:  2008

10.  Histological patterns of atherosclerotic plaques in unstable angina patients vary according to clinical presentation.

Authors:  J M Mann; J C Kaski; W I Pereira; S Arie; J A Ramires; F Pileggi
Journal:  Heart       Date:  1998-07       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.